Susan E. Ward, PhD
Dr. Susan Ward brings significant experience in pharmaceutical clinical development gained at Pfizer, Biogen, and Roche. She has an established track record in the design, leadership, and execution of innovative, cross-disciplinary clinical development programs.
Dr. Ward joins BrainStorm from Pfizer, where she was the head of early development clinical trial operations. She began at Pfizer as a clinician in Quantitative Medicine, leading human biology and exploratory research collaborations in biomarker, imaging, and mobile devices. At Biogen, she was a Senior Director and Clinical Program Lead in Translational and Experimental Medicine, where she developed exploratory studies to further research strategy across therapeutic indications in neurology.
Dr. Ward was a clinical consultant in neuroscience at Roche and held positions of increasing responsibility at both biotechnology and pharmaceutical companies, including OvaScience, EnVivo, and Sepracor. She also held the role of Vice President, Global Clinical Affairs at Clinquest, a contract research organization.
She earned a PhD in Behavioral Neuroscience from the Boston University School of Medicine in 2001, while working as a researcher and a Postdoctoral Training Fellow at the Harold Goodglass Aphasia Research Center from 1993 to 2002. She received a BA in Cognitive Science and Psychology from the University of Rochester.